Neutrophils Gelatinase Associated Lipocalin (NGAL ) - India CDSCO Medical Device Registration

Neutrophils Gelatinase Associated Lipocalin (NGAL ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000236_9abaaaac3feda31249be3383687e4124_d50bc471bb11b6166e7742d7a2ad4b99. This device is marketed under the brand name Immunofluorescence Assay. The license holder is Cosmic Scientific Technologies, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Neutrophils Gelatinase Associated Lipocalin (NGAL )

UID: IMP/IVD/2020/000236_9abaaaac3feda31249be3383687e4124_d50bc471bb11b6166e7742d7a2ad4b99

Brand Name

Immunofluorescence Assay

License Holder

Cosmic Scientific Technologies

Device Class

Class B

Approving Authority

CDSCO

Product Information

NGAL Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of neutrophils gelatinase associated lipocaln (Immunofluorescence Assay) in serum and urine. This test is used as an aid in the early diagnosis of acute kidney injury (Immunofluorescence Assay), risk classification and treatment monitoring